C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01) A61P 31/04 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2417311
Sodium, magnesium, lithium, potassium, calcium or barium salt of (R)-2-[[[3- methyl-4-(2,2,2-trifluoroethoxy)-2-pyri- dinyl]methyl]sulfinyl]-1H- benzimidazole; and pharmaceutical compositions containing such salts. These novel salts are useful as excellent antiulcer agents.
Cette invention a trait à un sel de sodium, de magnésium, de lithium, de potassium, de calcium ou de baryum de (R)-2-[[[3-méthyl-4-(2, 2, 2-trifluoroéthoxy)-2-pyri-dinyl]méthyl]sulfinyl]-1h-benzimidazole. Elle porte également sur des compositions pharmaceutiques contenant ces sels. Ces derniers se révèlent de remarquables agents anti-ulcéreux.
Hashimoto Hideo
Kamiyama Keiji
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
Takeda Pharmaceutical Company Limited
LandOfFree
Crystalline alkali metal salts of lansoprazole and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline alkali metal salts of lansoprazole and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline alkali metal salts of lansoprazole and their... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1611567